Dab tsi yog Bioglutide NA-931: Mechanism Thiab Health Applications

Cov tshuaj metabolic noj qab haus huv ib txwm hloov pauv vim tias cov txheej txheem tshiab tau tsim los uas tsom mus rau ntau yam txheej txheem physiological tib lub sijhawm.Tom ntej: Bioglutide NA-931yog ib qho ntawm cov tshuaj tshiab no uas siv txoj hauv kev nyuaj dua los tswj cov metabolism. Nws ua qhov no los ntawm kev ua kom muaj ntau yam receptors nyob rau hauv ib txoj kev uas cuam tshuam rau cov piam thaj homeostasis, kev siv lub zog, thiab lub cev muaj pes tsawg leeg. Tshawb nrhiav seb qhov no ntau npaum li cas - receptor agonist ua haujlwm yog qhov tseem ceeb rau kev nkag siab txog cov txheej txheem niaj hnub no pab cov metabolism thiab txhawb kev noj qab haus huv. Metabolic tsis ua hauj lwm yog dav dav, xav tau kev kho mob uas hais txog cov txheej txheem hauv qab tsis yog cov tsos mob. Ib leeg- txoj kev kho mob feem ntau qhia tau tias tsis muaj txiaj ntsig vim qhov nyuaj ntawm cov txheej txheem metabolic. Bioglutide NA-931 tau tsim los tshawb nrhiav kev ua kom muaj zog ntau ntxiv rau kev txhim kho metabolic. Cov txheej txheem no tshuaj xyuas nws cov txheej txheem molecular, kev sib cuam tshuam ntawm receptors, thiab cov ntaub ntawv siv tau hauv kev tshawb fawb thiab kev tsim kho tshuaj.

 

Tom ntej: Bioglutide NA-931

1. General Specification (hauv Tshuag)
(1) API (Ntshiab hmoov)
PE / Al foil hnab / ntawv lub thawv rau Pure hmoov
(2) Spot-On
(3) Kev daws teeb meem
(4) Poob
2.Customization:
Peb yuav sib tham tus kheej, OEM / ODM, Tsis muaj hom, rau kev tshawb nrhiav kev ruaj ntseg nkaus xwb.
Khoom siv: BM-1-154
TIAB SA-931
Kev tshuaj xyuas: HPLC, LC-MS, HNMR
Kev them nyiaj yug Technology: R & D Dept.-3

Peb muab Bioglutide NA-931, thov xa mus rau lub vev xaib hauv qab no kom paub meej cov lus qhia thiab cov khoom lag luam.

Khoom siv:https://www.bloomtechz.com/synthetic-chemical/peptide/bioglutide-na-931.html

Bioglutide NA-931 yog ib qho kev tsim peptide uas tau piav qhia los hloov kho ntau cov txheej txheem metabolic receptor nyob rau tib lub sijhawm. Nws tsom mus rau GLP-1, GIP, glucagon, thiab IGF-1 txoj hauv kev, taw qhia rau kev sib koom tes hormonal signaling suav nrog hauv kev tswj cov piam thaj, kho qhov tseem ceeb, thiab cov ntaub so ntswg digestion. Cov kev hloov pauv hloov mus rau pem hauv ntej receptor partiality thiab enzymatic steadiness, amplifying nws pab tau ib nrab-lub neej. Nws ua rau txiav txiav, daim siab, cov nqaij rog, cov leeg, thiab lub hauv paus kev ntxhov siab, tsim kom muaj kev cuam tshuam rau cov kab mob metabolic. Nws txoj kev npaj yuav tsum muaj kev sib xyaw ua ke, pom, thiab kev tswj xyuas nruj kom lav qhov sib xws, tsim txiaj, thiab tsim nyog rau kev nug txog thiab kev nce qib.

Txhawm rau kom nkag siab tias Bioglutide NA-931 ua haujlwm li cas, peb yuav tsum tau saib txhua qhov receptor system nws cuam tshuam nrog thiab vim li cas lawv txhua tus tau txais kev ua haujlwm ua ke.

GLP-1 Receptor Kev Koom Tes thiab Glucose-Dependent Insulin secretion

Tom ntej: Bioglutide NA-931enacts GLP-1 receptors ntawm pancreatic beta hlwb txhawm rau txhim kho cov piam thaj- nyob ntawm kev tawm tsam tawm tsam, txo qis kev pheej hmoo ntawm hypoglycemia piv nrog cov tsis muaj qabzib- nyob ntawm cov kws tshaj lij. Yav dhau los ntawm tus txiav, GLP-1 signaling moderates gastric purging thiab nce satiety los ntawm txoj kev hypothalamic, txo qis tus nqi khaws cia thiab kev ntshaw. Hauv lub hauv paus kev ntxhov siab, GLP-1 receptor actuation pab txhawb rau kev tswj kev xav ntev ntev. Kev ua kom zoo tshaj plaws ntawm cov khoom sib txuas ua kom lub sijhawm receptor enactment, txhawb kev ncua kev cuam tshuam ntawm metabolic thiab tejzaum nws txo cov koob tshuaj rov tshwm sim thaum ua kom ruaj khov glycemic tswj nyob rau ntau lub cev thiab cov xwm txheej.

GIP Receptor Activation thiab Metabolic Enhancement

GIP receptor actuation complements GLP-1 signaling los ntawm kev txhim kho affront paug tawm los ntawm unmistakable intracellular txoj kev nyob rau hauv pancreatic beta hlwb. Qhov kev ua ob zaug incretin no nce qib qabzib ua haujlwm thiab metabolic adaptability. Nyob rau hauv cov ntaub so ntswg rog, GIP signaling cuam tshuam rau lipid muaj peev xwm, cuam tshuam rau kev cuam tshuam, thiab kev faib tawm tseem ceeb, thaum tsim cov pov thawj pom zoo kom pom qhov tshwm sim hauv cov pob txha digestion. Thaum co- qhib nrog GLP-1, kev tawm tsam tawm tsam tag nrho yog nce ntxiv, tsim qhov chaw rau ntau cov txheej txheem metabolic. Bioglutide NA-931 tswj txoj hauv kev no kom txav mus rau pem hauv ntej kev tswj cov piam thaj thiab lipid saib xyuas, txhawb kev nthuav dav metabolic kho yav dhau los glycemic tswj ib leeg hauv kev sim.

Glucagon Receptor Activity thiab Energy Expenditure Modulation

Txawm hais tias glucagon nce ntshav qabzib, kev tswj hwm kev ua haujlwm tuaj yeem hloov kho qhov tseem ceeb siv los ntawm kev nthuav dav hepatic greasy oxidation thiab thermogenesis. Hauv ntau- cov txheej txheem receptor, glucagon's hyperglycemic cuam tshuam yog offset los ntawm GLP-1 thiab GIP-mediated affront tso tawm, ua kom glycemic ruaj khov. Qhov no ua kom yooj yim cov cim qhia nce kev siv lipid thaum xav tias xav tau qhov siab tsis txaus siab. Txoj hauv kev glucagon li no pab txhawb rau lub zog metabolic kho uas txhawb nqa qhov tseem ceeb ntawm kev hlawv thiab txo qis cov rog. Bioglutide NA-931 leverages no tswj enmity los txhim kho metabolic kev ua tau zoo thaum tiv thaiv cov piam thaj homeostasis hauv kev tshawb nrhiav qauv.

IGF-1 Receptor Influence ntawm cov txheej txheem Anabolic

IGF-1 receptor enactment muab anabolic rov qab rau hauv lub multi-receptor system, nce protein amalgamation, nqaij tu, thiab kev loj hlob ntawm cov ntaub so ntswg. Qhov no ua rau muaj qhov sib txawv tiv thaiv lub cev loj hauv nruab nrab ntawm kev hloov pauv hauv metabolic uas tau tsav los ntawm kev nthuav dav siv zog thiab tswj cov piam thaj. IGF-1 signaling dhau los cuam tshuam kev loj hlob ntawm tes, kev sib cais, thiab kev ciaj sia, txhawb nqa cov ntaub so ntswg ntev. Hauv kev sib xyaw nrog incretin thiab glucagon txoj hauv kev, nws ua rau muaj qhov sib txawv kho cov ntaub ntawv catabolic thiab anabolic, ua strides hauv lub cev muaj pes tsawg leeg. Bioglutide NA-931 koom tes IGF-1 kev txav mus los txhawb kev txhim kho metabolic thaum txo qis cov leeg nqaij tsis zoo thaum muaj roj tsawg thiab kev hloov pauv tseem ceeb.

Tom ntej: Bioglutide NA-931npaj cov piam thaj thiab qhov tseem ceeb ntawm lub plab zom mov los ntawm ntau -receptor enactment. GLP-1 thiab GIP teeb liab hloov kho cov piam thaj- nyob ntawm kev tawm tsam tawm tsam, ua rau cov ntshav qabzib qis thaum tswj hwm kev thuam raws li qib normalize. GLP-1 ntxiv rau stifles tsis raug glucagon tso tawm, ua rau cov ntshav qabzib hauv siab. Tswj glucagon receptor enactment bolsters ceev ceev vitality tawm los thiab increments rog oxidation tsis ua rau hypoglycemia. Ua ke nrog fringe cuam tshuam nyob rau hauv daim siab, nqaij, thiab cov nqaijrog, lub compound txav mus rau pem hauv ntej qab zib noj, affront cuam tshuam, thiab vitality siv, whereas central craving directions thiab metabolic hloov mus rau feem ntau kho vitality homeostasis.

Kev tswj hwm metabolic suav nrog kev tswj lub cev thiab kev coj tus cwj pwm, nrog Bioglutide NA-931 cuam tshuam rau lub hlwb-lub cev kev sib txuas lus uas saib xyuas qhov tseem ceeb hloov kho. Central GLP-1 receptors nyob rau hauv hypothalamus tswj kev tshaib plab, satiety, thiab noj qab haus huv remunerate, thiab lawv enactment hloov neuronal signaling hais txog kev ntshaw thiab noj hmo. Qhov kev cuam tshuam hauv nruab nrab no ua haujlwm nyob ze fringe metabolic kev ua ub no kom npaj tag nrho lub cev tseem ceeb hauv kev tswj hwm. Kev noj qab haus huv zais cia tshwm sim los ntawm cov khoom sib txawv, suav cov cim qhia txog kev noj qab haus huv, txo qis nqi zog-tsav noj, thiab txhim kho kev kuaj pom cov txheej txheem metabolic los ntawm hypothalamic circuits. Cov kev cuam tshuam no ua rau txo qis kev nkag mus rau kev noj haus thiab kho qhov tseem ceeb siv nrog kev xav tau ntawm lub cev.

Metabolic tswj nyob ntawm kev sib txuas lus bidirectional ntawm lub hauv paus thiab fringe moj khaum. Fringe metabolic hloov pauv cov teeb liab mus rau lub hlwb los ntawm txoj hauv kev ntawm neural thiab hormonal pathways, whereas central yields tswj fringe cov ntaub ntawv los ntawm autonomic thiab endocrine tswj. Bioglutide NA-931 locks nyob rau hauv ob qho tib si bearings ntawm lub teeb liab teeb tsa, tsim kev tswj xyuas cov piam thaj, lipid digestion system, thiab kev siv nyiaj tseem ceeb. Qhov sib xyaw ua ke cuam tshuam qhov tseem ceeb ntawm cov ntaub so ntswg sib txawv, suav lub siab, cov leeg nqaij, thiab cov nqaij rog, ua kom yooj yim rau kev hloov pauv hauv kev siv substrate thiab cuam tshuam rau kev cuam tshuam.

Cov kev cuam tshuam no ua rau muaj kev hloov pauv hauv cov txheej txheem metabolic lossis tej zaum tshaj cov lus teb ntawm cov ntaub so ntswg. Cov teebmeem tshwm sim nyob rau lub sijhawm sib txawv: kev hloov pauv ntawm cov tshuaj hormone emission thiab gastric purging, nruab nrab ntawm txoj kev hloov hauv qhov tseem ceeb siv, thiab ntev - kev hloov pauv hauv lub cev muaj pes tsawg leeg thiab kev tswj cov metabolism. Circadian rhythms tuaj yeem ua kom sib npaug cov kev cuam tshuam no, qhia lub sijhawm- nyob ntawm qhov cuam tshuam ntawm kev noj tshuaj thiab cov txiaj ntsig metabolic.

Tom ntej: Bioglutide NA-931tuaj yeem txhawb kev tshawb fawb txog kev noj qab haus huv hauv metabolic los ntawm kev tsom mus rau ntau txoj hauv kev koom nrog hauv kev tswj cov piam thaj, lipid metabolism, thiab lub zog sib npaug. Nws ntau yam -kev ua haujlwm receptor tuaj yeem cuam tshuam rau cov kab mob metabolic, muaj peev xwm txhim kho glycemic tswj, lipid profile, thiab lub cev muaj pes tsawg leeg. Los ntawm kev cuam tshuam kev siv hluav taws xob, kev noj qab haus huv cov cai, thiab cov teeb liab anabolic, nws tuaj yeem pab khaws cov nqaij ntshiv thaum txo cov rog. Cov ntawv thov tshawb fawb suav nrog kev laus- cuam tshuam txog kev poob qis hauv metabolic thiab kev tshawb fawb txog kev ua haujlwm rov qab. Nws kuj tseem raug txiav txim siab rau kev tsim kho tshuaj, yuav tsum muaj siab - zoo synthesis, nruj analytical validation, thiab txhim khu kev qha khoom chains rau kev tshawb fawb thiab formulation siv. Cov kev cai no suav nrog kev ua raws li Kev Tswj Xyuas Kev Ua Haujlwm Zoo, kev ua kom tsis zoo ntawm cov profile, thiab cov khoom siv rov ua dua tshiab -rau -batch sib xws. Advanced analytical techniques xws li huab hwm coj spectrometry thiab chromatographic txoj kev yog feem ntau siv los xyuas kom meej cov qauv thiab purity. Tsis tas li ntawd, ntev -kev tshawb fawb kev ruaj ntseg thiab qhov kub thiab txias- tswj kev thauj mus los yog qhov tseem ceeb los tswj kom muaj kev ncaj ncees thoob plaws hauv kev khaws cia thiab kev faib tawm, txhawb nqa cov ntaub ntawv tshawb fawb txog preclinical thiab kev soj ntsuam zoo thoob plaws ntau qhov chaw sim hauv kev tsim tshuaj.

Bioglutide NA-931 yog ib qho piv txwv ntawm yuav ua li cas cov tshuaj metabolic noj qab haus huv tau hloov lub sij hawm los ua hauj lwm nrog ntau tshaj ib txoj kev nyob rau tib lub sij hawm los ntawm activating txawv receptor systems. Nws ua haujlwm los ntawm kev txhawb nqa plaub receptors: GLP-1, GIP, glucagon, thiab IGF-1. Cov receptors no ua haujlwm ua ke los tswj cov qib qabzib, siv zog, qab los noj mov, thiab lub cev qauv. Cov txheej txheem nyuaj no ua rau nws txawv ntawm txoj kev kho ib leeg thiab qhia tau tias peb txoj kev paub txog kev tswj hwm cov metabolism hauv kev loj hlob li cas.

Cov khoom xyaw tuaj yeem siv los txhim kho cov metabolism, pab nrog lub cev qauv, ua kom cov metabolism tsis zoo uas tuaj yeem loj hlob tuaj, thiab hauv qee hom kev kawm. Tag nrho cov kev siv sib txawv no yuav tsum muaj siab - cov ntaub ntawv zoo, cov ntaub ntawv txheeb xyuas ntxaws, thiab cov kab xa khoom uas lawv tuaj yeem tso siab tau. Cov tuam txhab uas ua haujlwm zoo nrog cov tshuaj metabolic nyuaj ua haujlwm ua ke nrog cov neeg muag khoom uas muab ntau tshaj li cov khoom. Cov neeg muag khoom no kuj muaj kev paub, kev ruaj ntseg zoo, thiab kev txhawb nqa rau kev ua haujlwm ua ke. Cov tshuaj xws li Bioglutide NA-931 yuav dhau los ua qhov tseem ceeb dua li kev kawm txog kev noj qab haus huv hauv metabolic thiab kev tsim tshuaj txuas ntxiv mus. Los ntawm kev kawm txog lawv ua haujlwm li cas, lawv tuaj yeem siv tau li cas, thiab yuav ua li cas kom tau lawv, cov tuam txhab tuaj yeem siv cov cuab yeej nyuaj no los txhim kho cov txiaj ntsig kev noj qab haus huv.

1. Bioglutide NA-931 txawv li cas ntawm cov tshuaj biochemical uas tsuas siv ib txoj kev xwb?

Bioglutide NA-931 tig rau plaub qhov sib txawv receptor systems tib lub sijhawm: GLP-1, GIP, glucagon, thiab IGF-1. Qhov no tau koom ua ke cov teebmeem metabolic uas hloov cov piam thaj tswj, lub zog sib npaug, thiab lub cev qauv hauv ntau txoj hauv kev. Feem ntau, cov tshuaj ib leeg tsuas yog cuam tshuam rau ib qho receptor system, uas tuaj yeem ua rau muaj kev cuam tshuam ntawm lub cev. Cov txheej txheem multi-receptor yuav tsum muaj cov teebmeem uas muaj zog dua li qhov kev ua haujlwm ntawm tus kheej tuaj yeem ua tau. Qhov no yog vim tias kev tswj cov metabolism yog txuas nrog ntau lwm cov txheej txheem.

2. Cov qauv zoo li cas cov lag luam yuav tsum nrhiav thaum lawv yuav Bioglutide NA-931?

Cov khoom lag luam uas cov koom haum xav tau yuav tsum ua tau raws li cov kev xav tau tshwj xeeb ntawm lawv daim ntawv thov, txawm tias cov kev xav tau no yog kev tshawb fawb -qib lossis kws tshuaj- qib. Cov yam ntxwv tseem ceeb suav nrog kev ua pov thawj tias tus kheej siv ntau txoj hauv kev tshuaj ntsuam xyuas, qhia txog kev coj dawb huv tsawg kawg 98% los ntawm HPLC, muab cov ncauj lus kom ntxaws impurity profiles, cov ntaub ntawv ruaj khov, thiab cov ntaub ntawv raug cai los txhawb kev ua raws cai. Cov ntaub ntawv ua raws li GMP cov qauv muaj cov ntaub ntawv zoo tshaj plaws, cov ntaub ntawv khaws tseg, thiab daim ntawv pov thawj ntawm kev tshuaj xyuas los ntawm cov chaw pom zoo uas muaj kev pom zoo los ntawm tsoomfwv.

3. Lub multi-receptor system hloov li cas cov khoom siv hauv lub neej tiag tiag?

Cov txheej txheem nyuaj ua rau muaj kev pheej hmoo thiab yam xav txog. Nws muaj peev xwm hais tias cov tshuaj lom neeg ua ke yuav muaj kev cuam tshuam rau ntau yam ntawm kev noj qab haus huv tib lub sijhawm. Nkag siab txog cov koob tshuaj- teb kev sib raug zoo nyob rau hauv cov kev sib txawv receptor systems, muaj peev xwm cuam tshuam kev cuam tshuam, ib tug neeg teb variability raws li basal metabolic xeev, thiab txoj cai taug qab tsis ntsuas los ntsuas multidimensional metabolic kev hloov yog txhua yam uas yuav tsum tau xav txog. Cov khoom no cuam tshuam li cas txoj kev tshawb fawb tau tsim, cov txiaj ntsig tau soj ntsuam li cas, thiab seb daim ntawv thov zoo li cas.

Yuav kom tau nyob ib ncig ntawm lub ntiaj teb nyuaj ntawm cov tshuaj metabolic siab heev, koj xav tau ib tus neeg koom tes ua lag luam uas muab rau koj ntau tshaj li cov ntaub ntawv. BLOOM TECH yog qhov tsim nyogTom ntej: Bioglutide NA-931tus neeg muag khoom uas ua haujlwm nrog cov tuam txhab tshuaj, pab pawg kawm, CDMOs, thiab cov chaw sim tshwj xeeb thoob plaws ntiaj teb los muab cov kev daws teeb meem tiav. Peb 100,000-square-meter chaw tsim khoom yog GMP- ntawv pov thawj thiab tseem tuav cov ntawv pov thawj los ntawm US-FDA, EU, PMDA, thiab CFDA. Qhov no ua kom paub tseeb tias cov khoom peb siv tau raws li cov qauv zoo tshaj plaws thoob ntiaj teb. Peb 12 xyoo ntawm kev paub nyob rau hauv cov organic synthesis thiab tshuaj intermediates txhais tau hais tias peb yuav pab tau koj nyob rau hauv tag nrho cov theem ntawm koj tej yaam num, txij thaum pib ntawm kev kawm mus rau loj ntau lawm. Peb muab peb theem ntawm kev ruaj ntseg zoo: kev sim hauv cov nroj tsuag, sab hauv QA / QC tsom xam, thiab kev pom zoo thib peb. Qhov no lav qhov zoo ntawm cov ntaub ntawv, thiab peb cog lus tias yuav muab tag nrho cov nyiaj rov qab rau koj yog tias daim ntawv cog lus tsis ua raws. Peb qhov kev npaj them nqi meej ua kom cov nyiaj tau los tas li, yog li peb tuaj yeem muab cov nqi pheej yig yam tsis muaj kev txo qis lossis kev pabcuam.

Ntxiv nrog rau kev muab cov ntaub ntawv, peb kuj muaj kev txhawb nqa tag nrho, uas suav nrog kev pab tsim cov txheej txheem kev soj ntsuam, sau cov ntaub ntawv tswj hwm, thiab kev tsim cov kev cai uas tuaj yeem ntsuas los ntawm cov nqi me me hauv chav kuaj mus rau cov lej loj rau kev tsim khoom. Peb ERP- cov cuab yeej logistics sib xyaw ua ke tso cai rau koj pom cov khoom xa tuaj raws sijhawm thiab tau txais cov sijhawm tos kom raug, uas pab koj npaj koj cov haujlwm los ntawm kev ua kom cov saw hlau ua haujlwm zoo. Peb pab neeg tshaj lij tuaj yeem pab koj nrog txhua yam koj xav tau, txawm tias koj xav tau Bioglutide NA-931 rau kev kawm nrog cov ntaub ntawv CMC tag nrho lossis cov khoom siv rau kev siv tshuaj nrog cov ntaub ntawv qhia txog tus yam ntxwv. Hu rau BLOOM TECH tam sim ntawd los tham txog koj cov kev xav tau Bioglutide NA-931 thiab nrhiav seb peb cov kev paub zoo, kev paub, thiab kev pabcuam zoo npaum li cas tuaj yeem pab koj kom ncav cuag koj cov kev tshawb fawb thiab kev loj hlob ntawm metabolic. Koj tuaj yeem ncav cuag peb pab neeg ntawmSales@bloomtechz.comrau kev tawm tswv yim, quotes, thiab kev txhawb nqa tag nrho.

1. Müller TD, Finan B, Bloom SR, et al. Glucagon-zoo li peptide 1 (GLP-1). Molecular Metabolism, 2019; 30:72–130.

2. Holst JJ, Rosenkilde MM. GIP raws li Kev Kho Mob Lub Hom Phiaj hauv Kev Mob Ntshav Qab Zib thiab Kev rog: Kev Pom Zoo Los ntawm Incretin Co-agonists. Phau ntawv Journal of Clinical Endocrinology & Metabolism, 2020; 105 (8): e2710-e2716.

3. Capozzi ME, DiMarchi RD, Tschöp MH, Finan B, Campbell JE. Targeting Incretin / Glucagon System Nrog Triagonists los kho ntshav qab zib. Kev tshuaj xyuas endocrine, 2018; 39(5): 719-738 : kuv.

4. Brandt SJ, Götz A, Tschöp MH, Müller TD. Lub plab hormone polyagonists rau kev kho mob ntshav qab zib hom 2. Peptides, 2018; 100:190-201.

5. Nauck MA, Meier JJ. Kev tswj cov kab mob endocrine: Puas yog txhua tus GLP-1 agonists sib npaug hauv kev kho mob ntshav qab zib hom 2? European Journal of Endocrinology, 2019; 181 (6): R211-R234.

6. Finan B, Yang B, Ottaway N, et al. Ib tug rationally tsim monomeric peptide triagonist kho kev rog thiab ntshav qab zib hauv nas. Ntuj Tshuaj, 2015; 21(1):27-36.